With ma­jor back­ing from new in­vestors, Ce­lea Ther­a­peu­tics hopes to fol­low in the foot­steps of its sib­lings Sea­port Ther­a­peu­tics and Karuna Ther­a­peu­tics.

Ce­lea has cor­ralled...

Rev­o­lu­tion Med­i­cines on Thurs­day gave a first look at the ear­ly-stage da­ta that led it to plan a Phase 3 tri­al com­bin­ing two KRAS drugs...

🧬 Ver­tex’s sick­le cell gene ther­a­py ap­proved for kids: Cas­gevy may now be usedto treat ei­ther sick­le cell dis­ease with re­cur­rent va­so-oc­clu­sive crises...

Roche’s lung can­cer drug can­di­date di­vara­sib has beat­en mar­ket­ed drugs from Am­gen and Bris­tol My­ers Squibb in a head-to-head tri­al. Full da­ta haven't yet emerged...